SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

HC Wainwright Sets Coherus Oncology Price Target at $7.00 per Share

HC Wainwright & Co. assumed coverage of Coherus Oncology with a Buy rating and announced a $7.00-per-share price target.

CHRS

Related stories